Pulmatrix Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pulmatrix inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pulmatrix Inc Today - Breaking & Trending Today

Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research note released on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pulmatrix Stock Performance Shares of PULM opened at $1.88 on Friday. Pulmatrix has a twelve month low of $1.55 and a twelve month high of […] ....

United States , Pulmatrix Inc , Pulmatrix Company Profile , Free Report , Get Free Report , Pulmatrix Daily ,

Pulmatrix, Inc. (NASDAQ:PULM) Sees Significant Decrease in Short Interest

Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 400 shares, a drop of 86.2% from the April 30th total of 2,900 shares. Based on an average trading volume of 15,100 shares, the days-to-cover ratio is […] ....

United States , Pulmatrix Inc , Pulmatrix Company Profile , Get Free Report , Trading Down , Pulmatrix Daily ,

Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the biotechnology company’s stock. Pulmatrix Price Performance NASDAQ:PULM opened at $1.94 on Friday. The business’s 50-day moving average is $1.87 and its two-hundred day moving average is $1.88. Pulmatrix has […] ....

United States , Pulmatrix Company Profile , Pulmatrix Inc , Free Report , Get Free Report , Pulmatrix Daily ,

Pulmatrix : Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) - Form 8-K

Pulmatrix : Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Ted Raad , Timothy Mccarthy , Exchange Commission , Company Nasdaq , American Headache Society , Company Quarterly Reports On Form , Pulmatrix Inc , Pulmatrix Announces Peer Reviewed Publication , Clinical Results , Orally Inhaled , Acute Migraine , Chief Executive Officer , Annual Meeting , American Headache , Face Pain , Chronic Obstructive Pulmonary Disease , Annual Report , Quarterly Reports , Current Reports ,

Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100)

Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Ted Raad , Timothy Mccarthy , Pulmatrix Inc , Exchange Commission , Company Quarterly Reports On Form , American Headache Society , Company Nasdaq , Prnewswire Pulmatrix Inc , Orally Inhaled , Chief Executive Officer , Annual Meeting , American Headache , Face Pain , Chronic Obstructive Pulmonary Disease , Annual Report , Quarterly Reports , Current Reports ,